CoChat

Caffeine and Cardiometabolic Health: Evidence, Controversies, and Clinical Considerations

Kayikcioglu, Meral, Ozkan, Hasan Selcuk · 2026 · Nutrition Reviews

The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.

Abstract

Caffeine is the most widely consumed psychoactive substance globally, making its cardiometabolic effects particularly relevant, especially in individuals with established cardiovascular disease. This narrative review presents an overview of the current literature on caffeine and its impact on cardiometabolic risk factors by encompassing not only clinical but also mechanistic studies, eventually providing practical hints for clinical practice. A structured literature search was conducted via MEDLINE on caffeine and coffee in relation to cardiovascular health and disease. In patients with hypertension, caffeine intake is generally considered safe within certain limits, though individual factors, such as advanced age and CYP1A2 gene variants, may increase sensitivity. Caffeine’s effects on the lipid profile vary by preparation method, with filtered coffee being more favorable than unfiltered forms. Although caffeine can acutely impair glycemic control in patients with diabetes, long-term intake may reduce complications like metabolic dysfunction–associated steatohepatitis, though it may also worsen diabetic renal disease. Caffeine consumed before exercise may impair coronary vasodilation in patients with coronary artery disease and should be avoided in this setting. Although moderate intake is safe for most adults, excessive caffeine consumption, especially from energy drinks containing additional stimulants, can pose severe cardiovascular risks for vulnerable individuals, such as those with arrhythmias, hypertension, or genetic susceptibilities. Despite its widespread use, few health authorities and scientific societies offer detailed guidance on caffeine consumption. Significant heterogeneity in study design, dosage, and patient selection limits the ability to translate findings into clinical recommendations. A more personalized approach, incorporating genetic variability and standardized dosing, may help optimize both safety and potential therapeutic benefits.

Overview

Integrity signals

Registry

Crossref · 10.1093/nutrit/nuag018

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 2

Metadata

Authors
Kayikcioglu, M., & Ozkan, H. S.
Affiliations
  • Ege University (TR)
  • Department of Psychiatry and Psychotherapy, University Hospital Schleswig-Holstein , Lubeck,
Venue
Nutrition Reviews
Published
2026-03-13
ISSN
  • 0029-6643 (ISSN-L)
  • 1753-4887
OpenAlex
W7135209916
Cited by
1
References
128
Citations by year
2026: 1
FWCI
4.32
Type
journal article
Language
en
Open access
closed
Locations
  • Nutrition Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
caffeine, cardiometabolic health, cardiovascular disease, hypertension, coffee, lipid profile, filtered coffee, glycemic control, diabetes mellitus, nonalcoholic steatohepatitis, diabetic renal disease, coronary artery disease, physical activity, energy drinks, cardiac arrhythmias, caffeine safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.